Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TPTE2 pseudogene 3 (TPTE2P3) is a pseudogene related to the transmembrane phosphoinositide 3-phosphatase and tensin homolog 2 (TPTE2) gene. Pseudogenes are genetic sequences similar to normal genes but are non-functional due to disabling mutations or lack of regulatory elements. There is no evidence that TPTE2P3 encodes a protein or has any established biological function, disease association, or relevance as a therapeutic target. Some pseudogenes can have regulatory roles or be implicated in disease, but no such associations are known or reported for TPTE2P3. TPTE2 is a protein-coding gene, encoding a phosphoinositide phosphatase possibly involved in metabolism and signal transduction pathways. By contrast, TPTE2 pseudogene 3 is one of multiple pseudogenes derived from TPTE2, which are non-functional relics in the genome. Large numbers of pseudogenes are present in the phosphatase gene family, including up to 9 pseudogenes for TPTE2, but only rare pseudogenes (such as PTENP1) have known regulatory roles. As a pseudogene, it is not a protein, receptor, or enzyme, and is not therapeutically targeted.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TPTE2 pseudogene 3 (TPTE2P3).